Clever cancer strategies with FoxO transcription factors

Kenneth Maiese1, Zhao Zhong Chong, Yan Chen Shang

  • 1Division of Cellular and Molecular Cerebral Ischemia, Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. kmaiese@med.wayne.edu

Insights

Forkhead box O (FoxO) transcription factors show promise as cancer therapeutics by inducing apoptosis and cell cycle arrest. Further research into FoxO proteins could lead to novel cancer treatments with fewer side effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer affects a global population, necessitating improved therapies beyond current limitations.
  • Existing cancer treatments often have significant toxic side effects.
  • Mammalian forkhead transcription factors of the O class (FoxOs) are emerging as potential therapeutic targets due to their roles in cell death and proliferation.

Purpose of the Study:

  • To explore the potential of FoxO proteins as novel targets for cancer therapy.
  • To understand how FoxO proteins regulate pathways involved in cancer.
  • To investigate the translation of FoxO research into clinical applications.

Main Methods:

  • Review of existing literature on FoxO proteins and their role in cancer.
  • Analysis of FoxO's function in apoptosis, cell cycle arrest, and other cancer-related pathways.
  • Discussion of the integration of FoxO-modulated pathways in cancer treatment strategies.

Main Results:

  • FoxOs exhibit pro-apoptotic effects and can induce cell cycle arrest, making them attractive anti-cancer targets.
  • FoxOs regulate critical pathways including cell proliferation, metabolism, inflammation, and survival.
  • FoxO proteins also influence normal cell survival and longevity, requiring careful therapeutic modulation.

Conclusions:

  • FoxO transcription factors are versatile proteins with significant potential for developing novel cancer therapies.
  • Further elucidation of FoxO function in neoplastic growth is crucial for clinical translation.
  • Targeting FoxOs may offer a way to overcome limitations of current cancer treatments and reduce side effects.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...